Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Why FDA approval of sickle cell gene therapy is a ‘big deal’

Season 2023 Episode 354 | 5m 08s

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.

Major corporate funding for the PBS News Hour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer Cellular and Cunard Cruise Line. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.
Extras
September 24, 2026 - PBS News Hour full episode
How the diesel price spike is rippling through nearly every part of the economy
News Wrap: Netanyahu calls allegations of genocide in Gaza ‘the biggest lie'
Experts analyze what's at stake in the Trump-Xi summit
In a warming climate, should air conditioning be a right?
AI, trade, Iran and Taiwan top agenda at Trump-Xi summit
'We want more guardrails,' Kalshi CEO says as calls grow for prediction market regulation
Lock of hair settles questions about Thomas Jefferson and Sally Hemings
News Wrap: FBI investigating hacking group's claim it breached jobs website
At UN General Assembly, Iran's president responds to Trump's 'annihilation' threat